Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1960 1
1993 1
1994 1
1995 1
1996 3
2000 2
2001 5
2002 6
2003 2
2005 8
2006 4
2007 6
2008 6
2009 4
2010 2
2011 2
2012 5
2013 5
2014 1
2015 8
2016 13
2017 6
2018 6
2019 9
2020 10
Text availability
Article attribute
Article type
Publication date

Search Results

110 results
Results by year
Filters applied: . Clear all
Page 1
Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer.
Dehdashti F, Wu N, Bose R, Naughton MJ, Ma CX, Marquez-Nostra BV, Diebolder P, Mpoy C, Rogers BE, Lapi SE, Laforest R, Siegel BA. Dehdashti F, et al. Among authors: laforest r. Breast Cancer Res Treat. 2018 Jun;169(3):523-530. doi: 10.1007/s10549-018-4696-z. Epub 2018 Feb 13. Breast Cancer Res Treat. 2018. PMID: 29442264 Free PMC article.
Cardiac Applications of PET/MR Imaging.
Lau JM, Laforest R, Nensa F, Zheng J, Gropler RJ, Woodard PK. Lau JM, et al. Among authors: laforest r. Magn Reson Imaging Clin N Am. 2017 May;25(2):325-333. doi: 10.1016/j.mric.2016.12.007. Epub 2017 Feb 27. Magn Reson Imaging Clin N Am. 2017. PMID: 28390532 Review.
Cardiovascular PET/MRI: Challenges and Opportunities.
LaForest R, Woodard PK, Gropler RJ. LaForest R, et al. Cardiol Clin. 2016 Feb;34(1):25-35. doi: 10.1016/j.ccl.2015.08.002. Cardiol Clin. 2016. PMID: 26590777 Review.
Folate Receptor α-Targeted 89Zr-M9346A Immuno-PET for Image-Guided Intervention with Mirvetuximab Soravtansine in Triple-Negative Breast Cancer.
Heo GS, Detering L, Luehmann HP, Primeau T, Lee YS, Laforest R, Li S, Stec J, Lim KH, Lockhart AC, Liu Y. Heo GS, et al. Among authors: laforest r. Mol Pharm. 2019 Sep 3;16(9):3996-4006. doi: 10.1021/acs.molpharmaceut.9b00653. Epub 2019 Aug 16. Mol Pharm. 2019. PMID: 31369274
Medical imaging data in the digital innovation age.
Kesner A, Laforest R, Otazo R, Jennifer K, Pan T. Kesner A, et al. Among authors: laforest r. Med Phys. 2018 Apr;45(4):e40-e52. doi: 10.1002/mp.12794. Epub 2018 Mar 1. Med Phys. 2018. PMID: 29405298 Review.
Measurement Repeatability of 18F-FDG PET/CT Versus 18F-FDG PET/MRI in Solid Tumors of the Pelvis.
Fraum TJ, Fowler KJ, Crandall JP, Laforest RA, Salter A, An H, Jacobs MA, Grigsby PW, Dehdashti F, Wahl RL. Fraum TJ, et al. Among authors: laforest ra. J Nucl Med. 2019 Aug;60(8):1080-1086. doi: 10.2967/jnumed.118.218735. Epub 2019 Feb 7. J Nucl Med. 2019. PMID: 30733325 Free PMC article.
Myocardial glucose and fatty acid metabolism is altered and associated with lower cardiac function in young adults with Barth syndrome.
Cade WT, Laforest R, Bohnert KL, Reeds DN, Bittel AJ, de Las Fuentes L, Bashir A, Woodard PK, Pacak CA, Byrne BJ, Gropler RJ, Peterson LR. Cade WT, et al. Among authors: laforest r. J Nucl Cardiol. 2019 Nov 8:10.1007/s12350-019-01933-3. doi: 10.1007/s12350-019-01933-3. Online ahead of print. J Nucl Cardiol. 2019. PMID: 31705425
Cardiac Positron Emission Tomography-Magnetic Resonance Imaging: Current Status and Future Directions.
Lau JMC, Raptis DA, Laforest R, Nensa F, Zheng J, Gropler RJ, Woodard PK. Lau JMC, et al. Among authors: laforest r. J Thorac Imaging. 2018 May;33(3):139-146. doi: 10.1097/RTI.0000000000000327. J Thorac Imaging. 2018. PMID: 29489584 Review.
Reply to 'Is Cherenkov luminescence bright enough for photodynamic therapy?'.
Kotagiri N, Laforest R, Achilefu S. Kotagiri N, et al. Among authors: laforest r. Nat Nanotechnol. 2018 May;13(5):354-355. doi: 10.1038/s41565-018-0143-x. Nat Nanotechnol. 2018. PMID: 29728673 No abstract available.
Beyond whole-body imaging: advanced imaging techniques of PET/MRI.
Barnwell J, Raptis CA, McConathy JE, Laforest R, Siegel BA, Woodard PK, Fowler K. Barnwell J, et al. Among authors: laforest r. Clin Nucl Med. 2015 Feb;40(2):e88-95. doi: 10.1097/RLU.0000000000000567. Clin Nucl Med. 2015. PMID: 25188648 Review.
110 results
Jump to page